Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Lgr6 is a stem cell marker in mouse skin squamous cell carcinoma

Nature Genetics volume 49, pages 1624–1632 (2017)Cite this article

Subjects

Abstract

The G-protein-coupled receptors LGR4, LGR5 and LGR6 are Wnt signaling mediators, but their functions in squamous cell carcinoma (SCC) are unclear. Using lineage tracing in Lgr5-EGFP-CreERT2/Rosa26-Tomato and Lgr6-EGFP-CreERT2/Rosa26-Tomato reporter mice, we demonstrate that Lgr6, but not Lgr5, acts as an epithelial stem cell marker in SCCs in vivo. We identify, by single-molecule in situ hybridization and cell sorting, rare cells positive for Lgr6 expression in immortalized keratinocytes and show that their frequency increases in advanced SCCs. Lgr6 expression is enriched in cells with stem cell characteristics, and Lgr6 downregulation in vivo causes increased epidermal proliferation with expanded lineage tracing from epidermal stem cells positive for Lgr6 expression. Surprisingly, mice with germline knockout of Lgr6 are predisposed to SCC development, through a mechanism that includes compensatory upregulation of Lgr5. These data provide a model for human patients with germline loss-of-function mutations in Wnt pathway genes, including RSPO1 or LGR4, who show increased susceptibility to squamous tumor development.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Lgr6 expression increases with squamous tumor progression and Lgr6-GFP+ cells, not Lgr5-GFP+ cells, are localized within tumor epithelium.
Figure 2: Clonal expansion derived from Lgr6+ cells is observed in benign squamous tumors.
Figure 3: Clonal expansion derived from Lgr6+ cells in primary SCCs.
Figure 4: Lgr5 is expressed in rare single BCC cells but not in SCC cells, and Lgr6, and not Lgr5, is an SCC CSC marker.
Figure 5: Lgr6 is enriched in epidermal cells with stem cell properties and has growth-inhibitory effects in epidermal cell lines.
Figure 6: Lgr6 depletion increases proliferation in the epidermis and leads to expanded Lgr6-derived lineage tracing into the epidermis.

Accession codes

Primary accessions

Gene Expression Omnibus

References

  1. Blanpain, C. & Fuchs, E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat. Rev. Mol. Cell Biol. 10, 207–217 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Jaks, V., Kasper, M. & Toftgård, R. The hair follicle—a stem cell zoo. Exp. Cell Res. 316, 1422–1428 (2010).

    CAS  PubMed  Google Scholar 

  3. Kretzschmar, K. & Watt, F.M. Markers of epidermal stem cell subpopulations in adult mammalian skin. Cold Spring Harb. Perspect. Med. 4, a013631 (2014).

    PubMed  PubMed Central  Google Scholar 

  4. Powell, A.E. et al. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 149, 146–158 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Jensen, K.B. et al. Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis. Cell Stem Cell 4, 427–439 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Page, M.E., Lombard, P., Ng, F., Göttgens, B. & Jensen, K.B. The epidermis comprises autonomous compartments maintained by distinct stem cell populations. Cell Stem Cell 13, 471–482 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Veniaminova, N.A. et al. Keratin 79 identifies a novel population of migratory epithelial cells that initiates hair canal morphogenesis and regeneration. Development 140, 4870–4880 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Ito, M. et al. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat. Med. 11, 1351–1354 (2005).

    CAS  PubMed  Google Scholar 

  9. Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003–1007 (2007).

    Article  CAS  PubMed  Google Scholar 

  10. Plaks, V. et al. Lgr5-expressing cells are sufficient and necessary for postnatal mammary gland organogenesis. Cell Reports 3, 70–78 (2013).

    CAS  PubMed  Google Scholar 

  11. Flesken-Nikitin, A. et al. Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche. Nature 495, 241–245 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Ng, A. et al. Lgr5 marks stem/progenitor cells in ovary and tubal epithelia. Nat. Cell Biol. 16, 745–757 (2014).

    CAS  PubMed  Google Scholar 

  13. Liu, D. et al. Leucine-rich repeat–containing G-protein-coupled receptor 5 marks short-term hematopoietic stem and progenitor cells during mouse embryonic development. J. Biol. Chem. 289, 23809–23816 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Quigley, D.A. et al. Genetic architecture of mouse skin inflammation and tumour susceptibility. Nature 458, 505–508 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Jaks, V. et al. Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat. Genet. 40, 1291–1299 (2008).

    CAS  PubMed  Google Scholar 

  16. Snippert, H.J. et al. Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science 327, 1385–1389 (2010).

    CAS  PubMed  Google Scholar 

  17. Füllgrabe, A. et al. Dynamics of Lgr6+ progenitor cells in the hair follicle, sebaceous gland, and interfollicular epidermis. Stem Cell Rep. 5, 843–855 (2015).

    Google Scholar 

  18. de Lau, W. et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476, 293–297 (2011).

    CAS  PubMed  Google Scholar 

  19. Carmon, K.S., Gong, X., Lin, Q., Thomas, A. & Liu, Q. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/β-catenin signaling. Proc. Natl. Acad. Sci. USA 108, 11452–11457 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Gong, X. et al. LGR6 is a high affinity receptor of R-spondins and potentially functions as a tumor suppressor. PLoS One 7, e37137 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Glinka, A. et al. LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling. EMBO Rep. 12, 1055–1061 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Van Mater, D., Kolligs, F.T., Dlugosz, A.A. & Fearon, E.R. Transient activation of β-catenin signaling in cutaneous keratinocytes is sufficient to trigger the active growth phase of the hair cycle in mice. Genes Dev. 17, 1219–1224 (2003).

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Lo Celso, C., Prowse, D.M. & Watt, F.M. Transient activation of β-catenin signalling in adult mouse epidermis is sufficient to induce new hair follicles but continuous activation is required to maintain hair follicle tumours. Development 131, 1787–1799 (2004).

    CAS  PubMed  Google Scholar 

  24. Lowry, W.E. et al. Defining the impact of β-catenin/Tcf transactivation on epithelial stem cells. Genes Dev. 19, 1596–1611 (2005).

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Greco, V. et al. A two-step mechanism for stem cell activation during hair regeneration. Cell Stem Cell 4, 155–169 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Walker, F., Zhang, H.H., Odorizzi, A. & Burgess, A.W. LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines. PLoS One 6, e22733 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Wu, C. et al. RSPO2–LGR5 signaling has tumour-suppressive activity in colorectal cancer. Nat. Commun. 5, 3149 (2014).

    PubMed  Google Scholar 

  28. Parma, P. et al. R-spondin1 is essential in sex determination, skin differentiation and malignancy. Nat. Genet. 38, 1304–1309 (2006).

    CAS  PubMed  Google Scholar 

  29. Styrkarsdottir, U. et al. Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits. Nature 497, 517–520 (2013).

    CAS  PubMed  Google Scholar 

  30. Garcia-Closas, M. et al. Genome-wide association studies identify four ER negative–specific breast cancer risk loci. Nat. Genet. 45, 392–839 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Perez-Losada, J. & Balmain, A. Stem-cell hierarchy in skin cancer. Nat. Rev. Cancer 3, 434–443 (2003).

    CAS  PubMed  Google Scholar 

  32. Visvader, J.E. Cells of origin in cancer. Nature 469, 314–322 (2011).

    Article  CAS  PubMed  Google Scholar 

  33. Gonzalez-Suarez, E. et al. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 468, 103–107 (2010).

    CAS  PubMed  Google Scholar 

  34. Schramek, D. et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 468, 98–102 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Gupta, P.B., Chaffer, C.L. & Weinberg, R.A. Cancer stem cells: mirage or reality? Nat. Med. 15, 1010–1012 (2009).

    CAS  PubMed  Google Scholar 

  36. Schepers, A.G. et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337, 730–735 (2012).

    Article  CAS  PubMed  Google Scholar 

  37. Li, X.B. et al. Gastric Lgr5+ stem cells are the cellular origin of invasive intestinal-type gastric cancer in mice. Cell Res. 26, 838–849 (2016).

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Balmain, A. & Yuspa, S.H. Milestones in skin carcinogenesis: the biology of multistage carcinogenesis. J. Invest. Dermatol. 134 e1, E2–E7 (2014).

    PubMed  Google Scholar 

  39. McCreery, M.Q. et al. Evolution of metastasis revealed by mutational landscapes of chemically induced skin cancers. Nat. Med. 21, 1514–1520 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Driessens, G., Beck, B., Caauwe, A., Simons, B.D. & Blanpain, C. Defining the mode of tumour growth by clonal analysis. Nature 488, 527–530 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Barker, N. et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608–611 (2009).

    CAS  PubMed  Google Scholar 

  42. Barker, N. et al. Lgr5+ve stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6, 25–36 (2010).

    CAS  PubMed  Google Scholar 

  43. Zhu, L. et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457, 603–607 (2009).

    CAS  PubMed  Google Scholar 

  44. Grachtchouk, M. et al. Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populations. J. Clin. Invest. 121, 1768–1781 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  45. da Silva-Diz, V. et al. Progeny of Lgr5-expressing hair follicle stem cell contributes to papillomavirus-induced tumor development in epidermis. Oncogene 32, 3732–3743 (2013).

    CAS  PubMed  Google Scholar 

  46. Jackson, E.L. et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243–3248 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Lapouge, G. et al. Skin squamous cell carcinoma propagating cells increase with tumour progression and invasiveness. EMBO J. 31, 4563–4575 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  48. White, A.C. et al. Stem cell quiescence acts as a tumour suppressor in squamous tumours. Nat. Cell Biol. 16, 99–107 (2014).

    CAS  PubMed  Google Scholar 

  49. Chen, J. et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488, 522–526 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Boumahdi, S. et al. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature 511, 246–250 (2014).

    CAS  PubMed  Google Scholar 

  51. Oft, M., Akhurst, R.J. & Balmain, A. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat. Cell Biol. 4, 487–494 (2002).

    CAS  PubMed  Google Scholar 

  52. Wong, C.E. et al. Inflammation and Hras signaling control epithelial–mesenchymal transition during skin tumor progression. Genes Dev. 27, 670–682 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Yu, M. et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 487, 510–513 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Aszterbaum, M. et al. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat. Med. 5, 1285–1291 (1999).

    CAS  PubMed  Google Scholar 

  55. Eastburn, D.J., Sciambi, A. & Abate, A.R. Identification and genetic analysis of cancer cells with PCR-activated cell sorting. Nucleic Acids Res. 42, e128 (2014).

    PubMed  PubMed Central  Google Scholar 

  56. Eastburn, D.J., Sciambi, A. & Abate, A.R. Ultrahigh-throughput mammalian single-cell reverse-transcriptase polymerase chain reaction in microfluidic drops. Anal. Chem. 85, 8016–8021 (2013).

    CAS  PubMed  Google Scholar 

  57. Pellegrino, M. et al. RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures. BMC Genomics 17, 361 (2016).

    PubMed  PubMed Central  Google Scholar 

  58. Yi, J. et al. Analysis of LGR4 receptor distribution in human and mouse tissues. PLoS One 8, e78144 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Charafe-Jauffret, E. et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69, 1302–1313 (2009).

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Cheung, A.M. et al. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Leukemia 21, 1423–1430 (2007).

    CAS  PubMed  Google Scholar 

  61. Ginestier, C. et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555–567 (2007).

    CAS  PubMed  PubMed Central  Google Scholar 

  62. Corti, S. et al. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 24, 975–985 (2006).

    CAS  PubMed  Google Scholar 

  63. Tang, T. et al. A mouse knockout library for secreted and transmembrane proteins. Nat. Biotechnol. 28, 749–755 (2010).

    CAS  PubMed  Google Scholar 

  64. Yamamoto, Y. et al. Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with β-catenin mutations. Hepatology 37, 528–533 (2003).

    CAS  PubMed  Google Scholar 

  65. McClanahan, T. et al. Identification of overexpression of orphan G protein–coupled receptor GPR49 in human colon and ovarian primary tumors. Cancer Biol. Ther. 5, 419–426 (2006).

    CAS  PubMed  Google Scholar 

  66. Tanese, K. et al. G-protein-coupled receptor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation. Am. J. Pathol. 173, 835–843 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  67. Korinek, V. et al. Constitutive transcriptional activation by a β-catenin–Tcf complex in APC−/− colon carcinoma. Science 275, 1784–1787 (1997).

    CAS  PubMed  Google Scholar 

  68. Tian, H. et al. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 478, 255–259 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Wang, M.T. et al. K-Ras promotes tumorigenicity through suppression of non-canonical Wnt signaling. Cell 163, 1237–1251 (2015).

    CAS  PubMed  Google Scholar 

  70. Koo, B.K. et al. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 488, 665–669 (2012).

    CAS  PubMed  Google Scholar 

  71. Hao, H.X. et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485, 195–200 (2012).

    CAS  PubMed  Google Scholar 

  72. Gat, U., DasGupta, R., Degenstein, L. & Fuchs, E. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated β-catenin in skin. Cell 95, 605–614 (1998).

    CAS  PubMed  Google Scholar 

  73. Huelsken, J., Vogel, R., Erdmann, B., Cotsarelis, G. & Birchmeier, W. β-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 105, 533–545 (2001).

    CAS  PubMed  Google Scholar 

  74. van Genderen, C. et al. Development of several organs that require inductive epithelial–mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev. 8, 2691–2703 (1994).

    CAS  PubMed  Google Scholar 

  75. Lim, X. et al. Interfollicular epidermal stem cells self-renew via autocrine Wnt signaling. Science 342, 1226–1230 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  76. Merrill, B.J., Gat, U., DasGupta, R. & Fuchs, E. Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev. 15, 1688–1705 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  77. Niemann, C., Owens, D.M., Hülsken, J., Birchmeier, W. & Watt, F.M. Expression of ΔNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours. Development 129, 95–109 (2002).

    CAS  PubMed  Google Scholar 

  78. Choi, Y.S. et al. Distinct functions for Wnt/β-catenin in hair follicle stem cell proliferation and survival and interfollicular epidermal homeostasis. Cell Stem Cell 13, 720–733 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Beronja, S. et al. RNAi screens in mice identify physiological regulators of oncogenic growth. Nature 501, 185–190 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  80. Seibler, J. et al. Reversible gene knockdown in mice using a tight, inducible shRNA expression system. Nucleic Acids Res. 35, e54 (2007).

    PubMed  PubMed Central  Google Scholar 

  81. Herold, M.J., van den Brandt, J., Seibler, J. & Reichardt, H.M. Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats. Proc. Natl. Acad. Sci. USA 105, 18507–18512 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  82. Quintanilla, M. et al. Comparison of ras activation during epidermal carcinogenesis in vitro and in vivo. Carcinogenesis 12, 1875–1881 (1991).

    CAS  PubMed  Google Scholar 

  83. Portella, G. et al. Molecular mechanisms of invasion and metastasis during mouse skin tumour progression. Invasion Metastasis 14, 7–16 (1994-1995).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank D. Wu, P. T. Menchavez and P. Vuong for assistance with handling of mice and RNA samples and D.A. Quigley for help with analysis of microarray data. This work was supported by NCI grants CA084244, CA141455, CA176287 and R01CA184510 and by California Institute for Regenerative Medicine (CIRM) grant TG2-01153 to P.Y.H. Additionally, A.B. acknowledges support from the Barbara Bass Bakar Chair of Cancer Genetics, and P.Y.H. acknowledges support from the Agency for Science, Technology and Research (A*STAR). We are grateful to F. de Sauvage (Genentech) for provision of the Lgr6−/− mouse strain. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of CIRM or any other agency of the state of California.

Author information

Author notes

  1. Phillips Y Huang and Eve Kandyba: These authors contributed equally to this work.

Authors and Affiliations

  1. Helen Diller Family Comprehensive Cancer Center University of California, San Francisco, San Francisco, California, USA

    Phillips Y Huang, Eve Kandyba, Arnaud Jabouille, Atul Kumar, Kyle Halliwill, Melissa McCreery, Reyno DelRosario & Allan Balmain

  2. Genome Institute of Singapore, Singapore

    Phillips Y Huang

  3. Division of Translational Cancer Research, University of Lund, Lund, Sweden

    Jonas Sjolund

  4. Invitae Corp, San Francisco, California, USA

    Hio Chung Kang

  5. Institute of Cell Biology, ETH, Zurich, Switzerland

    Christine E Wong

  6. Taconic Biosciences GmbH, Cologne, Germany

    Jost Seibler & Vincent Beuger

  7. Mission Bio, Inc., San Francisco, California, USA

    Maurizio Pellegrino, Adam Sciambi & Dennis J Eastburn

  8. Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, USA

    Allan Balmain

Authors
  1. Phillips Y Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eve Kandyba
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arnaud Jabouille
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jonas Sjolund
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Atul Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kyle Halliwill
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Melissa McCreery
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Reyno DelRosario
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hio Chung Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Christine E Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jost Seibler
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Vincent Beuger
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Maurizio Pellegrino
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Adam Sciambi
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Dennis J Eastburn
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Allan Balmain
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

P.Y.H., E.K. and A.B. designed experiments. J. Seibler and V.B. generated and provided ES cells for creation of mouse strains. P.Y.H., E.K., J. Sjolund, A.K., R.D., H.C.K., A.J., M.P., A.S. and C.E.W. performed experiments. P.Y.H., E.K. and A.B. analyzed data. K.H. and M.M. carried out statistical analyses. P.Y.H., E.K. and A.B. wrote the manuscript, with contributions from the other authors.

Corresponding author

Correspondence to Allan Balmain.

Ethics declarations

Competing interests

D.J.E., M.P. and A.S. are employees of Mission Bio, Inc. A.B. is a member of the Scientific Advisory Board for Mission Bio, Inc.

Integrated supplementary information

Supplementary Figure 1 Representative localization of Lgr5-GFP and Lgr6-GFP expression within primary squamous carcinoma tissue.

Localized expression of Lgr5-GFP and Lgr6-GFP was investigated in primary squamous carcinomas (at 25 weeks after initial TPA treatment; n = 3 biological replicates each) by immunostaining against GFP (green) or keratin 14 (red) to identify cell populations specifically expressing stem cell and basal cell markers. (a,b) Representative sections from squamous tumors demonstrating that epithelial Lgr5-GFP expression is absent in SCC tissue. (c,d) H&E staining of serial sections of the immunostaining depicted in a and b. (e,f) Representative sections from squamous tumors revealing abundant Lgr6-GFP+ cells (green) localized in epithelial squamous carcinoma tissue. (g,h) H&E staining of the serial sections of immunostaining depicted in e and f. (i) Magnified region of Lgr6-GFP+ squamous carcinoma cells (green) that display reduced K14 expression (red). The white arrow indicates Lgr6-GFP+ (green) cells within the tumor tissue. The yellow box denotes the region of interest displayed as single-color channels in the panel to the right with nuclear DAPI staining (blue). The experiment was carried out using three independent biological replicates of Lgr5-GFP and Lgr6-GFP primary SCC tumors; representative images are provided. Scale bar, 50 μm.

Supplementary Figure 2 Lgr5+ cells are capable of giving rise to spindle carcinoma, but Lgr5 expression is not maintained in the resulting tumors.

Lgr5-EGFP-IRES-CreERT2+/–/KrasLSL-G12D/+ mice developed papillomas when challenged with a back wound stimulus, and some of the papillomas eventually progressed to malignancy. (a) H&E-stained section of unwounded adult back skin from Lgr5-EGFP-IRES-CreERT2+/–/KrasLSL-G12D/+ mice showing SG hyperplasia. (b) H&E-stained section of a typical papilloma harvested from Lgr5-EGFP-IRES-CreERT2+/–/KrasLSL-G12D/+ mice. The inset is a high-power view showing the epithelial morphology of the component tumor cells. (c) H&E-stained section of a malignant tumor harvested from Lgr5-EGFP-IRES-CreERT2+/–/KrasLSL-G12D/+ mice. The inset is a high-power view showing the spindle morphology of the component tumor cells. (d) Representative section showing anti-GFP immunofluorescence of normal adult skin from Lgr5-EGFP-IRES-CreERT2+/–/KrasLSL-G12D/+ mice. (e) Representative section showing anti-GFP immunofluorescence of a spindle carcinoma from Lgr5-EGFP-IRES-CreERT2+/–/KrasLSL-G12D/+ mice. (f,g) Three separate tumor cell lines were independently derived from Lgr5-EGFP-IRES-CreERT2+/–/KrasLSL-G12D/+ spindle carcinomas. (f) TaqMan analysis showing Lgr4, Lgr5 and Lgr6 expression levels in the tumor cell lines and control normal back skin samples. Two different exon-spanning Lgr5 TaqMan probes that target different regions of the Lgr5 transcript were used. Data are presented as mean ± s.e. ***P < 0.001. n = 3. (g) Image analysis showing native GFP fluorescence in cells grown on chamber slides. Clockwise from top right: Lgr5-EGFP-IRES-CreERT2+/–/KrasLSL-G12D/+ tumor line 1, tumor line 2, tumor line 3 and positive-control spindle carcinoma cell line (D3) infected with the GFP-expressing F1HtUTG lentiviral vector89. Dotted lines demarcate the basement membrane and the outline of the hair follicles. Asterisks denote the autofluorescent hair shaft. White arrowheads point to specific GFP (Lgr5) expression in the outer root sheath of the hair follicles. Scale bar, 50 μm.

Supplementary Figure 3 LGR reporter–Tomato lineage-tracing treatment regime and sample collection.

(a,b) Lineage tracing using Tomato expression driven from Lgr5 (a) and Lgr6 (b) was performed in chemically induced skin tumors from Lgr6-EGFP-CreERT2 and Lgr5-EGFP-CreERT2 mice crossed with Rosa26-LSL-Tomato reporter mice by standard DMBA treatment followed by 8 weeks of tumor promotion using TPA. Mice were then treated with tamoxifen (TAM), and papillomas were harvested at 2 d, 3 weeks and 6 weeks thereafter, to measure the extent of lineage tracing from either Lgr5-GFP- or Lgr6-GFP-positive stem cells.

Supplementary Figure 4 Dermal Tomato+ cells derived from Lgr5-GFP- and Lgr6-GFP-positive cells are observed in benign squamous tumors.

Lineage tracing of cells derived from Lgr5- and Lgr6-expressing cells was performed in chemically induced skin tumors from Lgr6-EGFP-CreERT2 and Lgr5-EGFP-CreERT2 mice crossed with Rosa26-LSL-Tomato reporter mice by standard DMBA treatment followed by 8 weeks of tumor promotion using TPA. Mice were then treated with tamoxifen (TAM), and papillomas were harvested at 3 weeks and 6 weeks thereafter, to measure the extent of lineage tracing from either Lgr5-GFP- or Lgr6-GFP-positive stem cells. (a–d) At 3 and 6 weeks after tamoxifen treatment, Tomato+ cells derived from Lgr5-expressing cells (a,c) and Lgr6-expressing cells (b,d) were both observed in the dermal component of papilloma tissue. The yellow dotted boxes demarcate the magnified regions of dermal Tomato+ cells in the insets. The white dotted line indicates epithelial–dermal border. The white arrow indicates dermal Tomato+ cells. DAPI staining (blue) was performed to localize nuclear staining in sections. The experiment was preformed once using three independent tumors; representative images are provided. Scale bar, 50 μm.

Supplementary Figure 5 Clonal expansion of cells derived from Lgr5-expressing cells is not observed in primary SCCs in vivo.

Lineage tracing of Lgr5-expressing cells was performed in the same chemically induced primary (1°) SCC from Lgr5-EGFP-CreERT2 mice crossed with Rosa26-LSL-Tomato reporter mice by standard DMBA treatment followed by 20 weeks of tumor promotion using TPA. Once the SCC was readily visible, the mouse was treated with tamoxifen (TAM), and 2 d later initial labeling of Tomato+ cells derived from Lgr5-expressing cells was examined in the tumor tissue. (a–d) At 2 d after tamoxifen treatment, only rare Tomato+ cells derived from Lgr5-expressing cells (red; b) were readily observed in SCC epithelium, suggesting that Lgr5 is not a CSC marker in primary SCCs in vivo. The yellow dotted boxes demarcate the magnified regions in the insets. The white line indicates the epithelial–dermal border. DAPI (blue) staining was used to visualize cell nuclei (b,d). (a,c) Serial H&E sections of the images depicted in b and d to provide tumor histology. One SCC was used in this study to specifically trace progeny derived from Lgr5-expressing cells in the same tumor in vivo over time. Scale bar, 50 μm.

Supplementary Figure 6 Lgr6-GFP-positive cells are found in carcinoma tissue but do not coexpress SOX2.

(a) Lgr6-GFP+ and Lgr5-GFP+ cells were quantified in primary carcinoma tissue sections (n = 15, 5 FOVs analyzed from 3 independent carcinoma samples). (b) Immunofluorescence for nuclear SOX2 (red) in papilloma tissue. (c) Nuclear SOX2 (red) expression in Lgr6-GFP+ (green) primary carcinoma tissue by immunofluorescence. DAPI (blue) counterstaining was preformed to detect cell nuclei. FOV, field of view; SCC, squamous cell carcinoma. Scale bar, 50 μm.

Supplementary Figure 7 Lgr5 is not expressed in immortalized keratinocyte and SCC cell lines.

Microarray expression analysis was performed on a panel of immortalized keratinocyte (NK and C5N), papilloma (P6, Mscp5, MscP1) and carcinoma cell lines. The cell lines used have been described previously (refs. 57, 90, 91 and references therein). All of the cell lines apart from NK, C5 and Hras-null cells have mutations in the Hras gene. The NK and C5 cells are wild type at Hras and Kras, and the Hras-null cell line has a mutation in Kras. Log2-transformed expression ≤4 corresponds to the background expression level.

Supplementary Figure 8 Lgr5 is not an SCC CSC marker.

(a–e) Lgr4 and Lgr6 multiplex in situ hybridization was performed in a selection of skin cell lines—the immortalized keratinocyte cell line NK (a), the SCC cell line A5 (b) and the spindle carcinoma cell line CarB (c), and PACS analysis was performed for in vivo Lgr4, Lgr5 and Lgr6 expression in primary squamous carcinoma epithelial tissue (d,e). The Lgr4 (purple, a,b; red, c) expression patterns are shown in the left panels, while Lgr6 (red) expression patterns are shown in the right panels. DAPI staining (blue) localizes cell nuclei. The yellow dotted boxes identify the magnified area in image insets. (d) PACS-based expression profile for Lgr4, Lgr5 and Lgr6 in cells derived from primary squamous carcinoma tissue. (e) In vivo PACS-based analysis of Lgr4-, Lgr5- and Lgr6-positive cell populations derived from primary squamous carcinoma tissue. LGR coexpression profiles are shown for each individual LGR-positive cell population in vivo. The experiments were repeated twice, and representative images provided. Scale bar, 50 μm.

Supplementary Figure 9 Non-leakiness of the Lgr6-EGFP-IRES-CreERT2 promoter.

Representative section showing back skin harvested from non-4OHT-treated Lgr6-EGFP-IRES-CreERT2+/–/R26RLacZ+/– mice that was processed for X-gal staining. Scale bar, 50 μm.

Supplementary Figure 10 Wnt signaling in SCCs from Lgr6-knockout mice.

Original western blot images used to display β-catenin (phospho- b-catenin, green box; total β catenin, red box) and β-actin (blue box) protein levels in Figure 6k.

Supplementary Figure 11 Proposed model for the role of Lgr6 in tumor fate decisions.

Lgr6+ stem cells in the skin are capable of giving rise to progeny that differentiate down either the epidermal or hair follicle lineage. Within these stem cells, Lgr6 positively regulates Wnt signaling and serves to restrain commitment down the epidermal lineage.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–11. (PDF 2210 kb)

Life Sciences Reporting Summary (PDF 130 kb)

Supplementary Table 1

Gene Ontology (GO) enrichment results for LGR family members in human HNSCC expression data. (XLSX 9 kb)

Supplementary Table 2

Correlation r values between genes in the canonical Wnt signaling pathway (GO:0060070) and LGR family members. (XLSX 9 kb)

Supplementary Table 3

Primers for qPCR-based expression analysis. (XLSX 8 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Huang, P., Kandyba, E., Jabouille, A. et al. Lgr6 is a stem cell marker in mouse skin squamous cell carcinoma. Nat Genet 49, 1624–1632 (2017). https://doi.org/10.1038/ng.3957

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.3957

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer